<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01778959</url>
  </required_header>
  <id_info>
    <org_study_id>IFIS</org_study_id>
    <nct_id>NCT01778959</nct_id>
  </id_info>
  <brief_title>Methods to Manage Intra-operative Floppy-iris Syndrome and Poor Pupil Dilation in Cataract Surgery</brief_title>
  <acronym>IFIS</acronym>
  <official_title>Methods to Manage Intra-operative Floppy-iris Syndrome and Poor Pupil Dilation in Cataract Surgery: an Exploratory Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vienna Institute for Research in Ocular Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vienna Institute for Research in Ocular Surgery</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cataract surgery is one of the most frequently performed surgeries worldwide and&#xD;
      complications are rare. However, there are factors that increase the risk of complications,&#xD;
      such as poor pupil dilation and intra-operative floppy iris syndrome (IFIS). Reasons for a&#xD;
      small pupil size are pseudoexfoliation syndrome (PXF) syndrome, uveitis or synechia and the&#xD;
      use of pilocarpin drops. IFIS is a syndrome usually caused by systemic alpha1-blockers&#xD;
      (foremost tamsulosin) used to treat benign prostatic hyperplasia.1,2 As described by Chang&#xD;
      and Campbell3 IFIS is characterized by billowing of a flaccid iris stroma, a propensity for&#xD;
      iris prolapse towards the phacoemulsification tip as well as towards the incisions and&#xD;
      progressive intra-operative pupil constriction.&#xD;
&#xD;
      Stopping tamsulosin pre-operatively did not show to effectively prevent IFIS.4,5 However, it&#xD;
      is of high importance to identify patients prior to surgery, who are treated with&#xD;
      alpha1-blockers, or patients with a small pupil size and poor pharmacological pupil dilation.&#xD;
      Some methods, such as intracameral injection of phenylephrine is only sufficient in a few&#xD;
      cases 6, and a disadvantage is the risk of a hypertensive episode.7 Another pharmacological&#xD;
      method is the use of atropine drops pre-operatively, but this method did not show to&#xD;
      sufficiently reduce IFIS.4&#xD;
&#xD;
      Different methods were shown to reduce intra-operative problems due to IFIS/small pupil size:&#xD;
&#xD;
      The use of highly cohesive ophthalmic viscosurgical devices (OVD), also called&#xD;
      viscoadaptives, such as sodium hyaluronate (e.g. AMO Healon5 or Croma Eyefill H.D.) help to&#xD;
      viscodilate the pupil and by resting on the iris during the entire phacoemulsification&#xD;
      procedure reduce the risk of iris prolapsing towards the incisions. This method is more&#xD;
      dependent on a central phacoemulsification technique and low fluidic parameters to allow the&#xD;
      OVD to stay on the iris during the entire procedure.8 In case of a small pupil, pupil&#xD;
      stretching with 2 instruments can be used additively.&#xD;
&#xD;
      Another option to stabilize the pupil size is the use of mechanical pupil expansion devices,&#xD;
      such as&#xD;
&#xD;
        1. Iris retractors - these devices are routinely used to dilate the pupil&#xD;
           intra-operatively. Typically, 4 or 5 iris retractors, also called iris hooks, are&#xD;
           inserted through 4-5 incisions. Usually, the IFIS pupil is very elastic and the risk of&#xD;
           overstretching is small.8&#xD;
&#xD;
        2. Pupil expansion rings, such as the Malyugin ring. This ring is placed on the pupil&#xD;
           margin with an injector through the main incision. It eliminates the need of additional&#xD;
           incisions and saves time.9&#xD;
&#xD;
      Rationale To compare different methods to manage IFIS and poor pupil dilation in cataract&#xD;
      surgery: a pupil expansion ring (Malyugin Ring), iris retractors (iris hooks) and a&#xD;
      viscoadaptive OVD.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean difference in flare (pre-operatively to 1 day post-operatively) between the OVD and the device group</measure>
    <time_frame>pre-operatively to 1 day postoperatively</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Management of Intraoperative Floppy-iris Syndrome and Small Pupils With Different Mechanical Devices</condition>
  <arm_group>
    <arm_group_label>standard OVD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Iris hooks</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Malyugin Ring</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>OVD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Malyugin Ring</intervention_name>
    <description>insertion of a Malyugin Ring to stabilite the pupil during cataract surgery</description>
    <arm_group_label>Malyugin Ring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Iris hooks</intervention_name>
    <description>insertion of iris retractors to stabilize the pupil during cataract surgery</description>
    <arm_group_label>Iris hooks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>standard OVD</intervention_name>
    <description>use of a standard cohesive OVD during cataract surgery</description>
    <arm_group_label>standard OVD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OVD</intervention_name>
    <description>use of a highly cohesive OVD during cataract surgery</description>
    <arm_group_label>OVD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age-related cataract&#xD;
&#xD;
          -  Age 21 and older&#xD;
&#xD;
          -  written informed consent prior to surgery&#xD;
&#xD;
          -  Small pupil group: Patients with a pupil size below 4.0 mm after pharmacological&#xD;
             dilation with tropicamide 1% and phenylephrine 2.5% gtt as used routinely for pupil&#xD;
             dilation,&#xD;
&#xD;
          -  IFIS group: Patients, who currently are or have been treated with Alpha-adrenergic&#xD;
             receptor antagonists (Tamsulosin- i.e. Alna ret.Â®)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy (pregnancy test will be taken pre-operatively in women of reproductive age)&#xD;
&#xD;
          -  Traumatic cataract&#xD;
&#xD;
          -  History of uveitis&#xD;
&#xD;
          -  Any ophthalmic pathology that could compromise the measurements&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oliver Findl, MD, MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>VIROS- Vienna Institute for Research in Ocular Surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oliver Findl, MD, MBA</last_name>
    <phone>+43 1 91021</phone>
    <phone_ext>84611</phone_ext>
    <email>oliver@findl.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>VIROS- Vienna Institute for Research in Ocular Surgery - Department of Ophthalmology, Hanusch Hospital Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1140</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Findl, MD; MBA</last_name>
      <phone>+43 1 91021 84611</phone>
      <email>oliver@findl.at</email>
    </contact>
    <investigator>
      <last_name>Nino Hirnschall, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sophie Tatzreiter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Weber, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <study_first_submitted>January 25, 2013</study_first_submitted>
  <study_first_submitted_qc>January 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2013</study_first_posted>
  <last_update_submitted>January 25, 2013</last_update_submitted>
  <last_update_submitted_qc>January 25, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 29, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vienna Institute for Research in Ocular Surgery</investigator_affiliation>
    <investigator_full_name>Prim. Prof. Dr. Oliver Findl, MBA</investigator_full_name>
    <investigator_title>Prim. Univ.-Prof. Oliver Findl, MD, MBA</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Miosis</mesh_term>
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Mydriasis</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

